Sue Mahony

Track

Insider profile

Currently holds positions in Assembly Biosciences Inc and Horizon Therapeutics PLC

Positions

Position Company Period
Independent Director Assembly Biosciences Inc Dec. 18, 2017 -
Independent Director Horizon Therapeutics PLC Aug. 1, 2019 -
Senior Vice President and President - Lilly Oncology Eli Lilly and Company Feb. 11, 2011 - Dec. 1, 2018
Sue Mahony's trades of Axsome Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
344.74
Quantity 94,894
Value US$4,407,267
Transaction date
Proposed sale
Price
237.21
Quantity 300
Value US$71,163
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-10 2026-06-10
PlS Planned sale
30,424 -20.4%
168.53
US$2,990,441 		30,424 -20.4% 168.53 US$2,990,441
2026-06-10 2026-06-10
PlS Planned sale
96,205 +48.4%
196.42
US$3,933,058 		96,205 +48.4% 196.42 US$3,933,058
2026-06-10 2026-06-10
PrS Proposed sale
94,894
344.74
US$4,407,267 		94,894 344.74 US$4,407,267
2026-06-10 2026-06-09
PlS Planned sale
300 -21.0%
237.21
US$71,163 		300 -21.0% 237.21 US$71,163
2026-06-10 2026-06-09
PlS Planned sale
300 -21.0%
237.21
US$71,163 		300 -21.0% 237.21 US$71,163
2026-06-09 2026-06-09
PrS Proposed sale
300
237.21
US$71,163 		300 237.21 US$71,163